Left ventricular hypertrophy and geometry in type 2 diabetes patients with chronic kidney disease. An echocardiographic study

Ventricular Hypertrophy ◽

Left Ventricular ◽

Echocardiographic Study ◽

Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure

Expert Review of Cardiovascular Therapy ◽

10.1586/erc.13.36 ◽

2013 ◽

Vol 11 (6) ◽

pp. 719-728 ◽

Cited By ~ 3

Author(s):

Giuseppe Derosa ◽

Pamela Maffioli

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

High Blood Pressure ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

SP061THE ROLE OF OXIDATIVE STRESS AND INFLAMMATION IN LEFT VENTRICULAR HIPERTROPHY IN TYPE 2 DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfy104.sp061 ◽

2018 ◽

Vol 33 (suppl_1) ◽

pp. i365-i365

Author(s):

Luísa Pereira ◽

Filipa Mendes ◽

Ana Silva ◽

Pedro Neves

Keyword(s):

Oxidative Stress ◽

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Left Ventricular ◽

Albuminuria increased the risk of left ventricular hypertrophy in type 2 diabetes patients with early renal insufficiency

International Journal of Diabetes in Developing Countries ◽

10.1007/s13410-021-00946-4 ◽

2021 ◽

Author(s):

Lei Liu ◽

Haizhao Luo ◽

Yi Shu ◽

Yunyi Liang ◽

Jielong Tang

Keyword(s):

Type 2 Diabetes ◽

Renal Insufficiency ◽

Ventricular Hypertrophy ◽

Left Ventricular ◽

Treatment Patterns in Type 2 Diabetes Patients with Chronic Kidney Disease-A Cohort Study

Diabetes ◽

10.2337/db18-536-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 536-P

Author(s):

MICHAEL BLANKENBURG ◽

CSABA P. KOVESDY ◽

SELINE EISENRING ◽

ANNE FETT ◽

EMILE W. SCHOKKER ◽

...

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Cohort Study ◽

Kidney Disease ◽

Treatment Patterns ◽

512-P: The Concomitant Insulin Treatment with Sodium–Glucose Cotransporter 2 Inhibitors Influenced the Renal Composite Outcome in Japanese Type 2 Diabetes Patients with Chronic Kidney Disease

Diabetes ◽

10.2337/db20-512-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 512-P

Author(s):

KAZUO KOBAYASHI ◽

MASAO TOYODA ◽

HIROYUKI SAKAI ◽

KOUICHI TAMURA ◽

NOBUO HATORI

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Insulin Treatment ◽

Composite Outcome ◽

Sodium Glucose Cotransporter ◽

Association of renal and cardiovascular safety with DPP‐4 inhibitors vs sulfonylureas in type 2 diabetes patients with advanced chronic kidney disease

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2262 ◽

2021 ◽

Author(s):

Chun‐Ting Yang ◽

Wei‐Hung Lin ◽

Lun‐Jie Li ◽

Huang‐Tz Ou ◽

Shihchen Kuo

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Cardiovascular Safety ◽

Advanced Chronic Kidney Disease ◽

DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease

Bone Research ◽

10.1038/s41413-019-0051-1 ◽

2019 ◽

Vol 7 (1) ◽

Cited By ~ 14

Author(s):

Corey Dussold ◽

Claire Gerber ◽

Samantha White ◽

Xueyan Wang ◽

Lixin Qi ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ventricular Hypertrophy ◽

Left Ventricular

Erythropoiesis-stimulating agents, hypertension and left ventricular hypertrophy in the chronic kidney disease patient

Current Opinion in Nephrology & Hypertension ◽

10.1097/mnh.0b013e3283497057 ◽

2011 ◽

Vol 20 (5) ◽

pp. 465-470 ◽

Cited By ~ 5

Author(s):

Holger Schmid ◽

Helmut Schiffl ◽

Stephan R. Lederer

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Chronic Kidney Disease Patient ◽

Ventricular Hypertrophy ◽

Disease Patient ◽

Left Ventricular ◽

Erythropoiesis Stimulating Agents

Determinants and Prognostic Significance of Electrocardiographic Left Ventricular Hypertrophy Criteria in Chronic Kidney Disease

Clinical Journal of the American Society of Nephrology ◽

10.2215/cjn.07770910 ◽

2010 ◽

Vol 6 (3) ◽

pp. 528-536 ◽

Cited By ~ 11

Author(s):

Rajiv Agarwal ◽

Robert P. Light

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ventricular Hypertrophy ◽

Prognostic Significance ◽

Left Ventricular

Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases

Diabetes Obesity and Metabolism ◽

10.1111/dom.14119 ◽

2021 ◽

Vol 23 (S2) ◽

pp. 19-27

Author(s):

Issei Komuro ◽

Takashi Kadowaki ◽

Johan Bodegård ◽

Marcus Thuresson ◽

Suguru Okami ◽

...

Keyword(s):

Heart Failure ◽

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Renal Diseases ◽

Sodium Glucose Cotransporter ◽

Disease Risks ◽